Why do people say Medicare Advantage plans are bad? Seven documented reasons

Short answer

Medicare Advantage now enrolls over 34 million beneficiaries — more than half of all Medicare-eligibles. It is popular for real reasons: lower premiums, extra benefits, and cost caps. But the same structural features that make it popular also create documented category-level limitations. This article walks through seven of them, each sourced to primary CMS, MedPAC, KFF, or GAO research. The point is not to say Medicare Advantage is a bad choice for everyone — it is to make the trade-offs visible.

Why the criticism of Medicare Advantage exists at all

Medicare Advantage is a private-plan alternative to Original Medicare that has grown rapidly over the last decade. More than half of Medicare-eligible beneficiaries now choose Medicare Advantage instead of fee-for-service. Plans compete on premium, extras, and network — and for many people, they deliver. For the foundational comparison between the two categories, see our Medicare Advantage vs Medicare guide.

At the same time, several structural features of the Medicare Advantage design create trade-offs that fee-for-service Medicare does not have. Federal regulators, independent analysts, and academic researchers have documented these trade-offs in public reports and data releases. The list below draws on those primary sources — with a citation for every limitation described.

The seven limitations do not apply equally to every plan. Some plans manage prior authorization more restrictively than others. Some networks are broader than others. Some carriers have cleaner marketing records than others. What the sources document are patterns at the program level — patterns worth weighing before you enroll in any Medicare Advantage plan.

Limitation 1 — Prior authorization

Medicare Advantage plans use prior authorization for many services, while Original Medicare rarely requires it. Kaiser Family Foundation’s analysis of CMS data for 2023 found that Medicare Advantage plans issued about 46 million prior-authorization determinations, with 3.4 million denied on first review. About 11% of appealed denials were overturned — a signal that many first-review denials were procedurally rather than clinically driven.

In 2026, a new federal rule (CMS-0057-F, the Interoperability and Prior Authorization Final Rule) begins standardizing how prior-authorization data is exchanged and requires plans to publicly report approval rates, denial rates, and decision times. Implementation is phased through 2026 and 2027. That is a partial correction to a documented friction point, still in early implementation.

Limitation 2 — Network geography constraints

Medicare Advantage plan networks are contracted per plan, per region, per year. A doctor who is in-network this year may not be next year. Original Medicare works with almost every physician and hospital nationwide because there is no network — any provider that accepts Medicare accepts your fee-for-service Medicare.

If you travel between states, split time seasonally, or rely on a specialist who happens to leave your Medicare Advantage network, this constraint can compromise care in ways that do not show up in the star rating. Kaiser Family Foundation and MedPAC have both documented year-to-year churn in Medicare Advantage networks; provider participation can shift outside the Annual Enrollment Period.

Limitation 3 — Referral-lock friction

Most Medicare Advantage HMO variants require primary-care referrals for specialist visits. That referral processing adds days to specialist access; some specialists refuse to book without an active referral on file. Original Medicare has no referral requirement.

For patients managing multiple chronic conditions across several specialists, the referral loop is friction, not care. A cardiologist appointment might need a referral from primary care, which might need a scheduling call, which might need a callback — all before the appointment can be booked. Over months of care, that friction accumulates.

Limitation 4 — Marketing-related enrollment complaints

CMS tightened Medicare Advantage marketing rules in the Contract Year 2026 Final Rule (CMS-4208-F) after multiple years of complaint patterns — TV advertising restrictions apply to certain misleading formats, and agent commission structures were revised. Complaint volumes had been high enough to trigger federal action in three consecutive years leading up to the 2026 rule.

This does not mean every carrier misbehaves. It does mean the enrollment process has had documented issues serious enough for federal remediation. If you have received a Medicare Advantage sales call that felt pressured, or seen a TV ad that felt misleading, the complaint pattern is real — and the 2026 rule is CMS’s answer to it.

Limitation 5 — Appeal-timeline friction

When care is denied or coverage is disputed on a Medicare Advantage plan, the appeal goes through the plan first — with strict internal timelines and a defined path to a federal Independent Review Entity. Original Medicare appeals move through a five-level federal process that is slower to start but grounded in federal statute at each stage.

The Medicare Advantage appeal path is faster on paper. Whether it produces the outcome you need depends heavily on plan-side procedural rigor. Appeal timelines and outcome patterns vary by plan — the newly-required public reporting under CMS-0057-F will make cross-plan comparisons possible over the next few years as data phases in.

Worth balancing this against outcome data: when appeals are actively pursued, a meaningful share of first-review denials are overturned — about 11% of appealed Medicare Advantage denials in the KFF analysis of 2023 CMS data. The friction is real; so is the ability to reverse a wrong denial when someone works the process on your behalf.

Limitation 6 — Benefit variance year-over-year

Medicare Advantage plan benefits, drug formularies, and provider networks can change every year. What was covered this year may not be next year. Original Medicare’s core benefits are set by federal statute — much more stable over time.

For patients on long-term care regimens, that year-to-year variance can require re-planning at every Annual Enrollment Period. A medication that was on the plan’s formulary last year may be excluded next year (or moved to a more expensive tier). A specialist who was in-network last year may be out next year. Coordinating that annual re-planning is one of the reasons patient advocacy exists as a service category.

Limitation 7 — Hospice coordination gaps

Medicare Advantage plans generally do not manage hospice benefits — hospice care is carved out to Original Medicare fee-for-service. The Value-Based Insurance Design (VBID) hospice demonstration attempted re-integration in some plans, but coordination gaps and provider confusion have been documented.

For families navigating end-of-life care, understanding the carve-out matters. When a Medicare Advantage enrollee elects hospice, the hospice benefit runs through Original Medicare, but other care may continue through the Medicare Advantage plan — and the boundary between the two is not always clear to families or providers.

What MedPAC has been saying

The Medicare Payment Advisory Commission (MedPAC) is an independent federal body that advises Congress on Medicare. In its March 2026 Report to the Congress, MedPAC flagged several payment-side concerns about Medicare Advantage:

• Payment adequacy. MedPAC estimates Medicare Advantage payments exceed equivalent fee-for-service spending by roughly 20% for equivalent beneficiaries.
• Coding intensity. MedPAC estimates coding intensity in Medicare Advantage is about 9 to 11% higher than in fee-for-service for the same beneficiaries, driving payment inflation.
• Star rating limitations. MedPAC continues to flag limitations of the star rating system as a quality signal, noting that measurement gaps and weighting choices affect what the ratings actually convey.

These are payment-side concerns, not care-quality concerns for individual enrollees. They matter because they shape the long-term sustainability of the program and the accuracy of the payment system that funds it.

What this means for you

Medicare Advantage is not universally bad. For many people — especially healthy low-utilizers and those who need included extras like dental and vision — it works well. The point of this article is not to talk you out of Medicare Advantage. It is to make sure your choice is informed.

If any of the seven limitations above intersects with your health situation, weigh it carefully. If you have a chronic condition that generates frequent prior authorizations, Limitation 1 matters more for you than for someone who rarely uses care. If you split time between states, Limitation 2 matters more. If you have a long specialist list, Limitation 3 matters. Match the limitations to your life, not to a generalized “for or against” position.

How Baba supports you around these limitations

A patient advocate maps the seven limitations against your specific care needs. If your Medicare Advantage plan is denying prior authorization on a needed service, we file the appeal. If your specialist just left the network, we identify alternatives. If your formulary changed and your medication is not covered next year, we start the exception process during Annual Enrollment.

Advocacy does not eliminate the limitations. It makes them manageable rather than exhausting.

Frequently asked questions

Are Medicare Advantage plans really bad?

No — and this article’s framing is that no plan category is universally bad. Medicare Advantage works well for many people. What is documented is a set of category-level trade-offs that fee-for-service Medicare does not have. Whether those trade-offs make Medicare Advantage a bad choice for you depends on your health, your providers, and your geography.

Why do people say never get an Advantage plan?

The “never get an Advantage plan” framing usually comes from experiences with one or more of the seven limitations covered above — a specialist dropped from a network, a prior-authorization denial that delayed care, a Medigap denial after trying to switch back. Those experiences are real, and the sources cited in this article document that they are not isolated. They are also not universal.

What are the biggest disadvantages of Medicare Advantage?

Prior-authorization volume, network geography constraints, referral-lock friction, appeal-timeline friction, year-over-year benefit variance, and marketing complaint patterns are the most commonly cited disadvantages in the primary-source literature. The seven limitations in this article are drawn from CMS, MedPAC, KFF, and GAO documentation.

Is Original Medicare better than Medicare Advantage?

Neither is better in absolute terms. Original Medicare gives you provider stability and cost predictability (usually paired with a Medigap policy) at the cost of a higher monthly premium. Medicare Advantage gives you a lower monthly cost, included extras, and an out-of-pocket cap at the cost of network restrictions and prior-authorization friction. Your specific situation decides which fits.

What percentage of prior authorization requests get denied?

Based on KFF’s analysis of CMS 2023 data, about 7.4% of Medicare Advantage prior-authorization determinations were denied on first review (3.4 million denials out of 46 million determinations). About 11% of appealed denials were overturned. Public reporting under CMS-0057-F will make plan-level detail available over the next few years as data phases in.

This information is for educational purposes and should not substitute for professional guidance. Healthcare coverage details vary by individual plan. Consult with Baba’s support team or your insurance provider for information specific to your situation.